Vivos (RDGL) Cash from Investing Activities Growth (1y) (2011 - 2013)
Vivos (RDGL) Cash from Investing Activities Growth (1y) (2011 - 2013) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -15.64% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | -514.42% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -73.71% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | -12.26% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 618.55% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 48.43% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 91.33% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 0.00% |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -100.00% |
| Jun 30, 2013 | 157.54% |
| Mar 31, 2013 | 50.12% |
| Dec 31, 2012 | 208.31% |
| Sep 30, 2012 | -291.65% |
| Jun 30, 2012 | 43.53% |
| Mar 31, 2012 | -201.98% |
| Dec 31, 2011 | -140.48% |
| Sep 30, 2011 | 67.18% |